[Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014]

D X Guan1, F H Yu, G L Wang

  • 1Department of Gastroenterology, Beijing Children's Hospital, Faculty of Digestive Diseases, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100045, China.

Insights

Pediatric inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is increasing. Early-onset and infantile IBD are common, with CD often presenting with perianal disease and UC involving extensive lesions.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Epidemiology

Background:

  • Inflammatory Bowel Disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC), affecting children with significant clinical challenges.
  • Understanding the evolving clinical characteristics and trends of pediatric IBD is crucial for effective management and treatment strategies.

Purpose of the Study:

  • To retrospectively analyze clinical data of pediatric patients diagnosed with IBD (CD and UC) between 2000 and 2014.
  • To identify key clinical characteristics, disease trends, and changes over a 15-year period in a pediatric cohort.

Main Methods:

  • Retrospective analysis of hospitalized pediatric patients diagnosed with IBD at Beijing Children's Hospital from 2000 to 2014.
  • Data categorized by disease type (CD, UC) and admission year into distinct groups for comparative analysis.

Main Results:

  • A total of 184 pediatric IBD cases were analyzed, with a notable increase in hospitalization ratios for both CD and UC over the study period (P<0.05).
  • Early-onset IBD, including very early onset and infantile IBD, constituted a significant proportion (61.4% and 41.8% respectively).
  • CD commonly presented as ileocolonic type with non-structuring behavior and perianal disease (31.1%), while UC frequently involved pancolitis (59.1%). Severe UC (S3) was more prevalent in earlier years (Group A2) compared to moderate UC (S2) in later years (Group C2) (P=0.0017).

Conclusions:

  • The incidence of pediatric IBD requiring hospitalization shows a growing trend, with a high prevalence of early-onset and infantile cases.
  • CD in children is often characterized by perianal disease and moderate to severe activity, with higher rates of surgery, obstruction, and perforation compared to UC.
  • UC cases frequently exhibit extensive colonic lesions and higher disease activity, with a shift towards less severe disease presentations in recent years.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
960
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
844
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
760
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
852